「Buddy」 ETH Long Position Faces Multiple Liquidations, Account Accumulates Losses Exceeding $19.35 Million

Per monitoring from 1M AI News, BrainWave AI’s earnings report grabbed Wall Street’s attention. While annual revenue surged over 100% year-over-year (YoY), the real shocker came from post-earnings real-time data: as of March 31, 2026, the company’s open platform API’s Annual Recurring Revenue (ARR) hit ~1.7 billion RMB (~$250 million) — up more than 240% from ~500 million RMB at the end of 2025, and a staggering ~60x (nearly 6000%) growth compared to 12 months prior. Both Morgan Stanley and J.P. Morgan flagged this as the report’s biggest surprise. Critically, the growth wasn’t just “quantity over quality.” J.P. Morgan noted in a research note that BrainWave’s API Token pricing has risen 83% year-to-date (YTD), while demand continues to accelerate. This rare volume-price sync — amid an ongoing domestic large-model price war — directly validates the firm’s strong pricing power in high-value use cases like programming and intelligent agents.

April 1st — Official data shows Hyperliquid has emerged as a key player in meeting trading demand when traditional financial markets are closed. In its perpetual contract market, six of the top 10 positions by 24-hour trading volume are tied to gold, silver, Brent crude, WTI crude, the Nasdaq 100 Index and the S&P 500 Index. Non-cryptocurrency trading volume on HIP-3 has surged to 45% of total platform volume, while open interest for non-crypto assets stands at $1.9 billion — 28% of the platform’s overall open interest.

**Uniswap Foundation Releases Unaudited 2025 Financial Summary** On April 1, the Uniswap Foundation published an unaudited financial update as of December 31, 2025. Key details: - Total assets: $85.8M (including $49.9M in cash/stablecoins, 15.1M UNI tokens, 240 ETH) - Current reserves expected to fund operations through January 2027 **Fund Allocation & Operations** - ~$106.2M earmarked for ecosystem grants and incentive programs; $26.3M for operating costs + employee token incentives - 2025 full-year operating expenses (excluding token compensation): $9.7M - 2025 interest income: $1.7M - Note: Allocations may adjust due to governance changes from the approved UNIfication proposal **Ecosystem & Institutional Updates** 2025 milestones: Launch of Uniswap v4, Unichain mainnet deployment, UNIfication fee switch activation. Proposed next steps: Enable protocol fees for v3 liquidity pools, expand on-chain deployments. Institutional: BlackRock and Securitize recently

On April 1st, Bitget market data shows spot gold topped $4,760 per ounce, with intraday gains widening to 2.00%. New York gold futures also climbed past $4,790 per ounce, up 2.39% on the day.

On April 1st, Ethereum Foundation researcher Devansh Mehta proposed a Validator Rewards Redistribution (VRR) scheme at the EthCC conference. Under the proposal, validators would be able to signal on the consensus layer and autonomously choose to redirect a portion of their staking rewards to a designated smart contract—rather than withdrawing all funds to their personal wallets. Recipients could include entities like Gitcoin, Octant, public goods funding platforms, security audit firms, and core protocol research teams. The scheme entails two Execution Layer changes: a mechanism for validators to signal their redirection percentage, and logic to transfer funds to the specified contract.

PR Newswire reported on April 1 that Bitcoin mining firm Cango Inc. (NYSE: CANG) has received a notice from the New York Stock Exchange (NYSE) stating it failed to meet the NYSE’s continued listing standard related to stock price. As of March 9, 2026, the average closing price of the company’s Class A common stock over 30 consecutive trading days was below $1.00 per share—violating Rule 802.01C of the NYSE Listed Company Manual. Under NYSE regulations, Cango has a 6-month cure period starting from the notice date. Compliance will be restored if, on the last trading day of any month during the cure period, both the closing price and the 30-trading-day average closing price are at or above $1.00 per share. Cango noted it has notified the NYSE of its intent to remedy the situation and will continue to assess market conditions and potential solutions. During the cure period, its Class A common stock will trade normally on the NYSE. The notice does not affect the company’s day-to-d